Abstract:Liying Sun, Xuhui Ye, Junping Yu, Linlin Wang, Yan Wu, Jing Cui, Lihua Dai Intensive Care Unit, Shidong Hospital, Shanghai, People's Republic of China Correspondence: Lihua Dai, Intensive Care Unit, Shidong Hospital, Yangpu District, Shanghai, 200438, People's Republic of China, Tel +86 18917059757, Email Purpose: Previous studies have reported that lymphocyte-to-monocyte ratio (LMR) is associated with the prognosis of patients with acute ischemic stroke (AIS); however, the relationship between LMR and early neurological deterioration (END) in AIS patients has not been elucidated. Patients and Methods: Patients were divided into two groups according to LMR by using receiver operating characteristic (ROC) curve analysis. Patients with END were confirmed as the National Institutes of Health Stroke Scale (NIHSS) increased ≥ 4 points between hospital days 0 and 5. Multivariate logistic regression analysis was used to analyze the factors independently related to END in patients with AIS. Results: In total, 202 patients diagnosed with AIS were enrolled in this retrospective study. Using ROC curve analysis, patients were divided into two groups according to LMR: low LMR group (LMR < 3.24, n = 95) and high LMR group (LMR ≥ 3.24, n = 107). The frequencies of END were significantly higher in the low LMR group compared to the high LMR group (41.05 vs.15.89%, p < 0.001). Multivariate logistic regression showed that age (OR = 1.03, 95% CI 1.01– 1.06, p = 0.04), infarct volume (OR = 1.01, 95% CI 1.00– 1.02, p = 0.001), neutrophil count (OR = 1.17, 95% CI 1.03– 1.33, p = 0.018), and LMR (OR = 2.49, 95% CI 1.01– 9.11, p = 0.018) were independently associated with END in AIS patients. Conclusion: A peripheral LMR levels at admission were significantly associated with END and LMR < 3.24 is an independent predictive factor of END in patients with AIS. Keywords: lymphocyte-to-monocyte ratio, acute ischemic stroke, early neurological deterioration, national institutes of health stroke scale Stroke is a serious threat to human health worldwide, and it has become one of the most common leading causes of death in China. 1 There are more than 13 million cases of stroke in China, of which 70 to 80% are ischemic stroke (IS). 2 Many efforts have been made to treat early acute ischemic stroke (AIS), including intravenous rt-PA thrombolysis and load-based anti-platelet aggregation therapy under the guidance of the CHANCE study. 3 However, despite regular treatment, there are still some patients with early neurological deterioration (END). 4 Although the exact definition of END is still controversial, current studies agree that END appears to be associated with long-term neurological impairment and is a predictor of poor functional outcome in stroke patients. Therefore, such patients should be given full medical attention in the course of treatment. 5 Many factors have been reported that may influence END, including neurological deficits at admission, hyperglycemia, diabetes, fibrinogen level and systolic blood pressure. 6–9 However, there are no peripheral blood indicators that can predict the development of END. A previous study found that a lower lymphocyte-to-monocyte ratio (LMR) value was independently related to the severity of coronary artery disease. 10 Qi et al suggested that LMR on admission could be a predictive indicator for neurological deterioration in the initial week after spontaneous intracerebral hemorrhage. 11 Ren et al reported that decreased LMR could predict poor prognosis of AIS in patients with thrombolysis. 12 Park et al found that LMR was significantly lower on days 1 and 7 in patients with AIS and pointed out that LMR was related to infection after stroke. 13 However, few studies have determined the relationship between LMR and END in patients with AIS. Therefore, this study explored factors associated with END and evaluated the predictive value of LMR as a prognostic biomarker of END in AIS patients. After reviewing AIS patients admitted to our institute between January 2023 and December 2023, we eventually enrolled 202 patients with AIS in this retrospective cross-sectional study. The inclusion criteria were as follows: (1) AIS confirmed by diffusion-weighted imaging (DWI), (2) onset of AIS symptoms within 24 h preceding admission and (3) timely assessment of NIHSS score in hospital. Patients with persistent neurological deficits caused by non-ischemic reasons were excluded, including cerebral hemorrhage, brain tumors, and traumatic brain injury; in addition, patients with infectious diseases, rheumatic immune diseases, severe liver or kidney impairment and malignant tumors were excluded. This study complied with th -Abstract Truncated-

Augmentation of Peripheral Lymphocyte-Derived Cholinergic Activity in Patients with Acute Ischemic Stroke

Risk Factors for Dysphagia in Patients with Acute and Chronic Ischemic Stroke: A Retrospective Cohort Study

Systemic immune responses after ischemic stroke: From the center to the periphery

Peripheral immunity is associated with cognitive impairment after acute minor ischemic stroke and transient ischemic attack

Dynamic Changes of Peripheral Blood Lymphocyte Subsets in Acute Ischemic Stroke and Prognostic Value

Early Neurological Deterioration in Patients with Acute Ischemic Stroke: a Prospective Multicenter Cohort Study

Change and predictive ability of circulating immunoregulatory lymphocytes in long-term outcomes of acute ischemic stroke

The characteristics of T‐cell receptor repertoire in relation to systemic immune response of patients with ischemic stroke

Temporal course of peripheral inflammation markers and indexes following acute ischemic stroke: prediction of mortality, functional outcome, and stroke-associated pneumonia

Admission serum cholinesterase concentration for prediction of in-hospital mortality in very elderly patients with acute ischemic stroke: a retrospective study

Peripheral Lymphocyte-to-Monocyte Ratio as a Predictive Factor for Early Neurological Deterioration in Patients with Acute Ischemic Stroke

Impact of peripheral lymphocyte subsets on prognosis for patients after acute ischemic stroke: A potential disease prediction model approach

Increased peripheral leukocyte aggravates brain injury and leads to poor outcome in stroke patients receiving intravenous thrombolysis: A study based on clinical evidence

Activation of Cholinergic Anti-Inflammatory Pathway Ameliorates Cerebral and Cardiac Dysfunction After Intracerebral Hemorrhage Through Autophagy

The impact of dysbiosis in oropharyngeal and gut microbiota on systemic inflammatory response and short-term prognosis in acute ischemic stroke with preceding infection

Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes

Novel Subsets of Peripheral Immune Cells Associated with Promoting Stroke Recovery in Mice.

High neutrophil percentage and neutrophil-lymphocyte ratio in acute phase of ischemic stroke predict cognitive impairment: A single-center retrospective study in China

Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke

Acute nicotine exposure attenuates neurological deficits, ischemic injury and brain inflammatory responses and restores hippocampal long-term potentiation in ischemic stroke followed by lipopolysaccharide-induced sepsis-like state

Communications Between Peripheral and the Brain-Resident Immune System in Neuronal Regeneration After Stroke